Related by context. All words. (Click for frequent words.) 63 cells/mm3 62 cells μL 62 serum albumin 61 neutrophil count 58 mm3 58 baseline CD4 58 creatinine ratio 57 median CD4 56 severe neutropenia 56 μg ml 56 Neutropenia 56 euthyroid 55 μmol L 55 elevated transaminases 55 NRTI backbone 55 fluticasone propionate FP 55 abacavir lamivudine 55 μg mL 55 pg ml 55 cells uL 55 leukocytosis 55 pmol L 55 lactate dehydrogenase 55 nadir CD4 cell 54 pneumocystis carinii pneumonia 54 Hgb 54 neutrophil counts 54 lymphocyte count 54 leukocyte count 54 leukopenia 54 baseline neutrophil counts 54 nM 54 mcg mL 54 ug ml 54 aPTT 54 Cmax 54 dehydroepiandrosterone sulfate 54 aspartate aminotransferase 54 plasma leptin 53 mL/min/#.# m 2 53 hMG 53 triglyceride concentrations 53 hemoglobin Hb 53 #ug [001] 53 bioavailable testosterone 53 haematological toxicity 53 alanine aminotransferase 53 CD3 + 53 â ‰ ¥ 53 log# copies mL 53 aspartate aminotransferase AST 53 Pharmacokinetics PK 53 leucopenia 53 CD4 + cell 52 pT3 52 RBC transfusion 52 umol L 52 milliliters mL 52 neutropenia dehydration dyspnea 52 absolute lymphocyte 52 serum creatinine levels 52 serum prostate 52 VELCADE melphalan 52 methylmalonic acid 52 mycophenolate 52 adjuvant cisplatin 52 4mg/kg 52 Amgen Neulasta ® 52 P = .# 52 doxorubicin cyclophosphamide 52 plasma folate 52 histologic subtype 52 albumin excretion 52 lopinavir r 52 urine albumin 52 deep venous thromboses 52 hematological parameters 52 normal ULN 52 lymphocytosis 52 BARACLUDE ® 51 cyclophosphamide methotrexate 51 pCR 51 #ug [002] 51 inhibitory concentration 51 dalteparin 51 hemoglobin concentration 51 SGPT 51 lactate dehydrogenase LDH 51 RBC folate 51 tipranavir r 51 ug dose 51 REYATAZ r arm 51 progression TTP 51 IPTp 51 parous women 51 adriamycin 51 pyrazinamide 51 % Confidence Interval 51 CD4 lymphocyte count 51 #ng/ml 51 #mg/m# [001] 51 PSA nadir 51 colorectal adenoma 51 VcMP 51 protein excretion 51 lipid elevations 51 mitoxantrone plus 51 anti HBs 51 aminotransferase levels 51 mIU mL 51 pmol liter 51 antiandrogen 51 β blocker 51 non splenectomized 51 saline placebo 51 bFGF 51 beclomethasone dipropionate 51 AZT zidovudine Retrovir 50 anagrelide 50 receiving INTRON 50 HBeAg seroconversion 50 mL/min/#.# m2 50 alanine aminotransferase ALT 50 rFSH 50 receiving ISENTRESS 50 lamivudine zidovudine 50 pg mL 50 Neutrophil 50 antithymocyte globulin 50 SCr 50 antibody titer 50 achieved ACR# 50 AZT 3TC 50 lumbar spine BMD 50 micromoles 50 piperacillin tazobactam 50 ovarian carcinoma 50 lymphoid blast 50 ug mL 50 serum ALT 50 nevirapine NVP 50 coinfection 50 indinavir 50 tumor histology 50 % CI #.#-#.# [003] 50 creatinine clearance 50 -#.# log# copies mL 50 cotrimoxazole 50 mg/m2 dose 50 #mg BID [003] 50 VIRAMUNE R 50 #mg/kg [002] 50 CK MB 50 nevirapine Viramune 50 cells mcL 50 mIU ml 50 mg qd 50 serum urate levels 50 Kinoid 50 flutamide 50 HbA1C levels 50 hypogonadal 50 CI -#.# 50 μg liter 49 #mg/m# [002] 49 autoantibody levels 49 Viral load 49 highest tertile 49 baseline CD4 + 49 rizatriptan 49 extracapsular extension 49 lowest tertile 49 ertapenem 49 intravenous bolus 49 serum PTH 49 antidiabetic drug 49 genotype 1b 49 treatment naive genotype 49 TPV r 49 combination antiretroviral therapy 49 statistically significant predictor 49 microliter 49 microg 49 ß blockers 49 8mg/kg 49 rhGH 49 emtricitabine tenofovir 49 peginterferon alfa 2b 49 conventional DMARDs 49 #OHD 49 seropositivity 49 biochemical relapse 49 serum urate 49 neutropenia 49 mycophenolate mofetil MMF 49 baseline LDH 49 mEq L 49 #mg QD [002] 49 nonnucleoside reverse transcriptase inhibitors 49 ng dL 49 mitoxantrone chemotherapy 49 albumin excretion rate 49 darunavir r 49 serum potassium 49 Pneumocystis carinii pneumonia 49 initiating antiretroviral therapy 49 glulisine 49 febrile neutropenia 49 erythrocyte sedimentation rate 49 parasitemia 49 5-FU/LV 49 mU liter 49 fosamprenavir 49 plus prednisone 49 indinavir Crixivan 49 mg/m2/day 49 #.#ng/ml 49 HES CEL 49 NRTI resistance 49 confidence interval #.#-#.# 49 daily subcutaneous injections 49 nmol liter 49 hemoglobin concentrations 49 TAXOTERE R 49 Capecitabine 49 subcutaneous dose 49 serum concentrations 49 NPH insulin 49 β blockers 49 HBV DNA levels 49 kg -1 49 parasitaemia 49 μg d 49 serum phosphate levels 49 ethambutol 49 % CI #.#-#.# [006] 48 estramustine 48 PSADT 48 mcg BID 48 endometrial thickness 48 certolizumab 48 #μg [002] 48 protease inhibitor PI 48 sulphadoxine pyrimethamine 48 specific antigen PSA 48 p = .# [002] 48 serum aminotransferase levels 48 patients coinfected 48 % CI #.#-#.# [007] 48 mmHg diastolic 48 pegIFN 48 interferon alfa 2b 48 6 mercaptopurine 48 HER2 expression 48 hepatorenal syndrome 48 virologic suppression 48 bacillus Calmette Guerin 48 PEG IFN 48 mutated K ras 48 leukemia AML 48 IXEMPRA 48 LEXIVA r 48 CRp 48 achieved undetectable HCV 48 hypophosphatemia 48 Telintra 48 atazanavir ritonavir 48 humoral responses 48 LV dysfunction 48 Flu Cy 48 sUA 48 g dl 48 mcL 48 glomerular filtration rate 48 peginterferon alpha 2a 48 huN# DM1 48 clobetasol 48 weekly subcutaneous injections 48 sulphadoxine 48 AOR = 48 antiandrogens 48 LPV r 48 peginterferon alfa 48 detectable HCV RNA 48 T2DM 48 ZDV 48 % CI #.#-#.# [008] 48 mg m² 48 BENICAR HCT 48 CsA 48 x ULN 48 salmeterol fluticasone 48 liver histology 48 benazepril 48 stage IIIb IV 48 virologic failure 48 transferrin saturation 48 serum testosterone 48 platelet counts 48 CC genotype 48 reactogenicity 48 CD4 + 48 viral titers 48 polycythemia vera essential thrombocythemia 48 investigational integrase inhibitor 48 nonmetastatic 48 Peginterferon 48 intramuscularly 48 ribavirin therapy 48 tumors GIST 48 tirofiban 48 elevated ALT 48 PASI score 48 doxorubicin docetaxel 48 virus HBV 48 HIV RNA 48 retransplantation 48 FOLFIRI alone 48 serum calcium levels 48 hemoglobin A1c HbA1c 48 HBeAg 48 doublet chemotherapy 48 salmeterol fluticasone propionate 48 hyperphenylalaninemia HPA due 48 mg ustekinumab 48 ug kg 48 p = #.# [003] 48 CCyR 48 naïve HCV 48 #.#mg/dL 48 transaminase levels 48 Relapsed Refractory 48 peak plasma concentrations 48 tipranavir ritonavir 48 e antigen HBeAg 48 IU ml 48 HGPIN 48 zidovudine lamivudine 48 melphalan prednisone 48 #mmHg [002] 48 titers 48 DAS# remission 47 abacavir Ziagen 47 containing abacavir 47 HbA 1c levels 47 mg subcutaneous 47 platelet count 47 mmol liter 47 PEGylated anti 47 HBeAg negative 47 ritonavir boosted protease inhibitor 47 danazol 47 receiving prophylactic anticoagulation 47 serum IgE 47 elevated hsCRP 47 seronegative 47 thiazides 47 serum phosphate 47 CLINICAL STUDIES 47 lispro 47 HBsAg 47 undetectable viral 47 Cutaneous T 47 budesonide pMDI 47 ritonavir boosted 47 hematologic toxicity 47 CI #.#-#.# [001] 47 serum HCV RNA 47 FUSILEV enhances 47 paclitaxel carboplatin 47 confidence interval CI 47 histologically confirmed 47 CD4 + cells 47 attain statistical significance 47 Adjuvant chemotherapy 47 hepatic fibrosis 47 HCV genotype 47 Q2W 47 amprenavir 47 pyrimethamine 47 nanomolar 47 plus medroxyprogesterone acetate 47 preterm neonates 47 plus COPEGUS 47 glycated hemoglobin levels 47 ® lenalidomide 47 pamidronate 47 gemcitabine carboplatin 47 genotypic resistance 47 HIV uninfected 47 BALB c mice 47 chlorambucil 47 mm ³ 47 HIV coinfected 47 lamivudine refractory patients 47 EGFR TKI 47 Pegylated interferon 47 radiotherapy RT 47 lymphocyte counts 47 Combination antiretroviral therapy 47 recurrent genital herpes 47 platelet reactivity 47 DOXIL ® 47 serum progesterone 47 receiving VICTRELIS 47 μg kg 47 acute GvHD 47 #mg/dl 47 cisplatin gemcitabine 47 operable breast cancer 47 thyroid stimulating hormone 47 KRAS mutant tumors 47 urinary albumin excretion 47 thrombocytopenic 47 gemcitabine cisplatin 47 ALT elevations 47 CD# upregulation 47 nadolol 47 QTcF 47 MENOPUR 47 R# R# [001] 47 HIV seroprevalence 47 gastric pH 47 nmol L 47 GH deficiency 47 mm Hg systolic 47 anthracycline therapy 47 Forodesine HCl 47 neurologic progression 47 Doxil ® 47 unresectable tumors 47 TT genotype 47 relapsed MM 47 biochemical recurrence 47 oral antidiabetic medication 47 undetectable HBV DNA 47 homocysteine concentrations 47 clodronate 47 mg BID 47 concomitant antibiotics 46 HIV coinfection 46 #mg q8h 46 plus OBT 46 alfa 2a 46 tTG 46 maintaining Hb 46 myelodysplastic myeloproliferative diseases 46 #mg/day [001] 46 antiretroviral naïve 46 initiating HAART 46 neutropenic patients 46 Pred Forte 46 complete cytogenetic response 46 Calcium intake 46 Lenalidomide 46 non splenectomised 46 MULTAQ 46 intratympanic 46 atazanavir 46 uninfected infants 46 FRAGMIN 46 Zometa hazard 46 liposomal amphotericin B 46 IgM 46 poor metabolizers 46 aged ≥ 46 mcg dose 46 pegfilgrastim 46 Protease Inhibitors 46 RhD negative 46 norethindrone 46 mU L 46 prevalent vertebral fracture 46 acromegalic patients 46 Myelosuppression 46 Retreatment 46 recurrent glioblastoma multiforme 46 cervicitis 46 BCG vaccinated 46 Hazard Ratio 46 Hb A1C 46 K ras mutations 46 HBsAg positive 46 serum sodium 46 administered subcutaneously 46 recurrent VTE 46 cubic millimeter 46 adjunctive placebo 46 mIU L 46 posttransplant 46 castrate resistant 46 Decitabine 46 3TC lamivudine Epivir 46 extensive metabolizers 46 subcutaneous enoxaparin 46 ASCUS 46 R entecavir 46 detemir 46 mmHg systolic 46 baseline Hb 46 5 Fluorouracil 46 mg q#h 46 HCV genotype 1 46 lopinavir 46 IPAH 46 μg dose 46 CYP#D# genotype 46 #.#g/day 46 response CCyR 46 stavudine d4T 46 virological suppression 46 polyp recurrence 46 #mmHg [001] 46 ErbB2 positive 46 K#N 46 q#h 46 ALT normalization 46 progesterone receptor negative 46 median PFS 46 nmol l 46 clomiphene citrate 46 Isoniazid 46 hormone refractory 46 underwent surgical resection 46 saquinavir 46 irbesartan 46 atazanavir Reyataz 46 oral prednisolone 46 mg orally 46 posaconazole 46 osteopenic 46 intradermal injections 46 Pegasys plus Copegus 46 Peginterferon alfa 2b 46 ceftriaxone 46 rilpivirine 46 antiretroviral naive 46 generalized edema 46 iPTH 46 efavirenz emtricitabine 46 prostate cancer mCRPC 46 steroid dexamethasone 46 ritonavir boosted atazanavir 46 del 5q MDS 46 nelfinavir 46 #mg/day [002] 46 mg p = 46 sacral neuromodulation 46 ascending doses 46 chronic HCV genotype 46 efavirenz EFV 46 d4T stavudine Zerit 46 neurodevelopmental impairment 46 NNRTI resistance 46 glycosylated hemoglobin levels 46 anemia hemoglobin 46 SLNB 46 baseline HbA1c 46 #Gy 46 oral vancomycin 46 virologic response 46 FTC TDF 46 -#.# mg dL [002] 46 autoantibody positive 46 HCV Genotype 46 remission CR 46 Mg Uk 46 TNF antagonist 46 CR nPR 46 atorvastatin #mg 46 administering XIFAXAN 46 TURBT 46 EGFR mutation positive 46 serum uric acid 45 maximal doses 45 recombinant follicle stimulating 45 virologic breakthrough 45 nucleoside analog 45 HBeAg + 45 transaminase elevations 45 IOP lowering 45 daunorubicin 45 tamoxifen Nolvadex ® 45 mcg kg REBETOL 45 de novo AML 45 serum testosterone levels 45 mg kg dose 45 seroprotection 45 seroconverted 45 primaquine 45 oocytes retrieved 45 binary restenosis 45 Abacavir 45 Median PFS 45 TDF FTC 45 mRCC 45 anovulation 45 IFN alfa 45 oral budesonide 45 azathioprine 45 DOXIL 45 comparator arm 45 concentration Cmax 45 mg tid 45 Darunavir 45 taxotere 45 tigecycline 45 log# reduction 45 immunosuppressives 45 pulmonary exacerbation 45 Emtriva Viread 45 tenofovir Viread 45 lopinavir ritonavir Kaletra 45 Peg IFN 45 PegIFN 45 Thal Dex 45 Pemetrexed 45 BEXXAR Therapeutic Regimen 45 recurrent venous thromboembolism 45 APTIVUS r 45 microbiologically evaluable 45 CD4 count 45 log# IU mL 45 mg TID 45 fluticasone salmeterol 45 incidence ≥ 45 severe renal impairment 45 Folfox 45 REYATAZ ® 45 epithelial ovarian 45 KRAS mutations 45 Ishak fibrosis score 45 node metastases 45 sUA levels 45 oxycodone IR 45 #.#/#.# mmHg [001] 45 chlorthalidone 45 #.#mmHg 45 enfuvirtide 45 mmol l 45 mcg doses 45 GnRH antagonist 45 neutropenic 45 epoetin alfa 45 HIV HCV coinfected 45 μg L 45 ORENCIA ® 45 placebo PBO 45 recurrent metastatic 45 ALT elevation 45 HBeAg positive 45 mg simvastatin 45 CD4 counts 45 RNA copies mL 45 tenofovir emtricitabine 45 CIN3 45 mesalamine granules 45 receiving APTIVUS r 45 HbA1C 45 pegylated IFN 45 timepoints 45 tenofovir TDF 45 plasma uric acid 45 Saquinavir 45 COMBIVIR 45 Kaplan Meier analysis 45 Contrave# 45 plasma glucose 45 #.#/# [005] 45 uncomplicated malaria 45 cranial irradiation 45 splenectomized patients 45 OADs 45 metastatic GIST 45 docetaxel Injection Concentrate 45 monoinfected patients 45 CYP#D# inhibitor 45 micrograms mL 45 prednisone prednisolone 45 CAELYX 45 scintigraphic 45 adefovir treated 45 antibody titers 45 peginterferon alfa 2a #KD 45 antibiotic azithromycin 45 cytidine nucleoside analog 45 underwent resection 45 R abatacept 45 placental malaria 45 Peginterferon Alfa 2a 45 octreotide LAR 45 CI #.#-#.# [002] 45 transaminases 45 nucleoside naive 45 systemic immunosuppressive 45 receiving antiretroviral therapy 45 definite stent thrombosis 45 NSTE ACS 45 Paraplatin ® 45 QVAR R 45 baseline A1C 45 Kivexa 45 epithelial ovarian cancer 45 KRAS mutations occur 45 onset idiopathic hypogonadism 45 atrophic vaginitis 45 colorectal carcinoma 45 hours postdose 45 bolus dose 44 efavirenz Sustiva 44 telaprevir dosed 44 virological response 44 Univariate analysis 44 CD4 cell 44 adenoma recurrence 44 eculizumab therapy 44 immunocompetent patients 44 oxycodone CR 44 intradermal injection 44 treatment naïve genotype 44 imipenem 44 mg/m2 IV 44 hematologic abnormalities 44 fasting plasma glucose FPG 44 undetectable virus HCV 44 low dose cytarabine 44 HAART regimen 44 RBC transfusions 44 polytherapy 44 LNG IUS 44 GnRH agonist 44 Zidovudine Tablets 44 underwent liver transplantation 44 microlitre 44 Antiretroviral treatment 44 imiquimod cream 44 FOLFOX4 alone 44 macrolide antibiotic 44 amisulpride 44 tropism testing 44 oral rivaroxaban 44 pentoxifylline 44 Stage IIB 44 Femara letrozole 44 plasma cortisol 44 sulfadoxine pyrimethamine 44 cubic milliliter 44 luteal 44 immunosuppression therapy 44 methotrexate monotherapy 44 mg QD 44 virological failure 44 HER2 overexpression 44 antidiabetic medications 44 nonpregnant 44 ng mL 44 ACEIs 44 Lupuzor ™ 44 serum HBV DNA 44 interferon alfa 2a 44 mg dosed twice 44 LHRH agonists 44 inhaled budesonide 44 placebo p = 44 abnormal cytology 44 adjunctive ABILIFY 44 #mg ATC 44 g dL 44 antitrypsin 44 Amodiaquine 44 Inhibin B 44 thyrotropin levels 44 mg/m2 44 subcutaneous immunoglobulin 44 CIMZIA TM certolizumab pegol 44 HBeAg positive patients 44 golimumab CNTO 44 Bezielle 44 labetalol 44 #OHD levels 44 ddI 44 enterococcal 44 GHRH 44 VLBW 44 ng ml 44 pulmonary exacerbations 44 dasatinib Sprycel ® 44 Heavy menstrual bleeding 44 oxcarbazepine 44 #mg dose [003] 44 hip BMD 44 G CSFs 44 trimethoprim sulfamethoxazole 44 + PH# 44 Kaletra lopinavir ritonavir 44 tenofovir FTC 44 suboptimal adherence 44 azilsartan medoxomil 44 vincristine doxorubicin 44 combination REBETOL PEG 44 HBeAg negative patients 44 CMV infection 44 ml kg 44 refractory NSCLC 44 coinfected 44 seropositive 44 anthracycline taxane 44 serum potassium levels 44 reduce serum phosphate 44 liver enzymes ALT 44 intravenous vancomycin 44 hormone receptor negative 44 mycophenolate mofetil 44 biologic DMARD 44 urothelial bladder cancer 44 aminotransferases 44 amodiaquine 44 ® emtricitabine 44 ABC/3TC 44 idraparinux 44 IM progesterone 44 neoadjuvant 44 CrCl 44 FOLPI 44 #mg dose [002] 44 stage IIIB 44 subcutaneous insulin 44 Natalizumab 44 mCi m 2 44 HER2 negative 44 undetectable viral load 44 GI toxicity 44 undergo prostate biopsy 44 serum PSA 44 -#.# log# 44 ritonavir boosted lopinavir 44 infliximab monotherapy 44 clomipramine 44 mmol L 44 acetazolamide 44 INTRON therapy 44 relapsed ovarian cancer 44 Anti retroviral therapy 44 evaluable subjects 44 q8h 44 lenalidomide dexamethasone 44 CANCIDAS 43 peg IFN 43 INVEGA ® 43 minimally symptomatic metastatic castrate 43 NovoLog ® Mix 43 gonorrhoeae 43 postmenopausal osteoporotic women 43 Isentress raltegravir 43 dapagliflozin plus 43 undetectable viral loads 43 #,# [004] 43 dosage regimens 43 artemether lumefantrine 43 stavudine 43 Epoetin Alfa 43 dexamethasone Decadron 43 tolterodine ER 43 vaginal hysterectomy 43 ipsilateral stroke 43 Viread Emtriva 43 noncarriers 43 MAXALT 43 MADRS score 43 Aptivus ® 43 Pneumonia vaccine 43 advanced adenoma 43 virologic failures 43 decompensated liver disease 43 induced tumor regression 43 interquartile range 43 IU mL 43 plus methotrexate 43 Acute myeloid leukemia 43 antiretroviral regimen 43 MAGE A3 ASCI 43 nephrotoxic 43 pegylated interferon alpha 43 recombinant FSH 43 Antiretroviral ARV 43 antithrombotic agent 43 seminoma 43 mitoxantrone 43 nitrofurantoin 43 Cotrimoxazole 43 antiplatelet medications 43 chlamydial infection 43 ARB telmisartan 43 interferon ribavirin 43 ibandronate 43 plasma viremia 43 stavudine lamivudine 43 chronic HBV 43 suppressive therapy 43 TMP SMX 43 Hb levels 43 corticosteroid dose 43 polysaccharide vaccine 43 highly emetogenic 43 mg d 43 Fansidar 43 Pegylated Interferon 43 IFN α 43 hepatitis C genotype 43 achieved CCyR 43 lopinavir r arm 43 pegylated interferon alfa 43 NOLVADEX 43 cisplatin chemotherapy 43 visceral metastases 43 hepatic metastases 43 anthracycline containing 43 nonfasting triglyceride levels 43 gastrointestinal stromal tumors GIST 43 AZT zidovudine 43 hemorrhagic complications 43 tenofovir DF 43 plus dexamethasone 43 chlamydial 43 #.#-#.# [005] 43 lamivudine stavudine 43 bolus injection 43 plasma concentrations 43 morphometric vertebral fractures 43 SVR# 43 dapsone 43 FOLFOX4 43 dose cohort 43 sero positive 43 BRCA2 mutation carriers 43 dacarbazine 43 q#d 43 COPD exacerbation 43 lopinavir ritonavir plus 43 plasma HCV RNA 43 serum lipid levels 43 peginterferon alfa 2a 43 evaluable 43 zidovudine AZT 43 virologically 43 palivizumab 43 ribavirin RBV 43 Artemether 43 lamivudine resistant 43 #.#mmol l [002] 43 cGy 43 hypomagnesemia 43 tetanus toxoid 43 genital herpes infections 43 Anti Retroviral drugs 43 palifermin 43 Rifampin 43 Selective serotonin reuptake inhibitors 43 serum phosphorus levels 43 rapid virological response 43 treatment naļve 43 mcg kg 43 sulfadoxine 43 #mg/dL [001] 43 FOLFIRI 43 debulking surgery 43 corifollitropin alfa 43 Durezol 43 paraprotein 42 dosing frequency 42 tumor regressions 42 F du Preez 42 Platinol ® cisplatin 42 Valtrex valacyclovir 42 Zoledronic acid 42 dosing cohorts 42 zidovudine 42 low dose Iluvien 42 BRCA1 mutation carriers 42 multivariate analyzes 42 undergone splenectomy 42 mcg albinterferon alfa 2b 42 advanced adenomas 42 Elitek 42 FIRMAGON 42 Chlamydia trachomatis infection 42 #mg BID [001] 42 postoperative chemotherapy 42 ,5 42 basal bolus regimen 42 Highly Active 42 3mg/kg 42 cervical intraepithelial neoplasia 42 seroprotective 42 P. falciparum malaria 42 cEVR 42 hemagglutination inhibition 42 HAQ DI 42 PegIFN RBV